Fertility Leadership CooperGenomics is a global leader in reproductive genetic testing, offering expanded PGT-A via PGTai along with PGT-M, PGT-SR and ERPeak endometrial receptivity testing. This breadth creates a compelling value proposition for fertility clinics and IVF centers seeking comprehensive, end-to-end genetic workflows to improve outcomes.

Integrated Portfolio Being part of the CooperSurgical family enables potential cross selling of genetic testing with lab automation, surgical products, and workflow solutions for IVF labs, increasing adoption and the sticky value for clinics.

ABM and Compliance Its technology stack including OneTrust and 6sense supports privacy compliance and account based marketing, allowing targeted, compliant outreach to fertility clinics and labs with high intent signals, improving lead quality for sales teams.

Growth Opportunity The market for PGT and endometrial testing is expanding, presenting opportunities to win share from mid to large fertility labs and to form partnerships with clinics scaling up high throughput reproductive genetics programs.

Competitive Differentiation CooperGenomics can differentiate on specialized test coverage and end to end reproductive genetics solutions, including ERPeak, to attract clinics seeking advanced, integrated testing beyond general genome screening offered by broader genetics players.